Corneal Hysteresis: A key biomarker in Glaucoma management
- Grafton Optical
- 4 days ago
- 1 min read
Corneal Hysteresis (CH) is now recognised as a clinically significant biomarker in Glaucoma assessment and risk stratification. A recent Eye News article highlights how CH measurements can provide valuable insight into disease progression. Read the full article here.
Corneal Hysteresis in clinical practice: CH reflects the cornea’s biomechanical properties—its ability to absorb and dissipate energy—which complements traditional metrics such as intraocular pressure (IOP) and central corneal thickness (CCT). Evidence indicates that lower CH values correlate with increased susceptibility to glaucoma progression, making it a relevant parameter for risk stratification and treatment planning in hospital-based ophthalmology departments.
Reichert ORA G3: advanced measurement for clinical settings: The Reichert Ocular Response Analyser (ORA) G3 is a non-invasive device that provides precise CH measurements alongside IOP values. Its dynamic bidirectional applanation process captures the cornea’s biomechanical response to a controlled air pulse, delivering reproducible data for clinical decision-making. The ORA G3 is designed for integration into hospital workflows, supporting specialists in identifying high-risk patients and monitoring disease progression.
Clinical implications for Ophthalmology departments:
Enhanced risk assessment: CH measurement provides an additional parameter for identifying patients at greater risk of Glaucoma related damage
Data-driven decision making: Reliable CH values assist in tailoring intervention strategies, including medication adjustments or surgical planning.
Patient management: Incorporating CH into routine glaucoma evaluation supports proactive monitoring and personalised care pathways.
The Reichert ORA G3 equips ophthalmology teams with precise, actionable data to optimise patient outcomes. For further insight into the role of CH in clinical practice, see the Eye News article: Corneal Hysteresis: An Emerging Biomarker in the Management of Glaucoma.
